HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure.

AuthorsHaye H van der Wal, Niels Grote Beverborg, Jozine M Ter Maaten, Joanna S J Vinke, Martin H de Borst, Dirk J van Veldhuisen, Adriaan A Voors, Peter van der Meer
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 22 Issue 5 Pg. 903-906 (05 2020) ISSN: 1879-0844 [Electronic] England
PMID32243649 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Iron
Topics
  • Aged
  • Aged, 80 and over
  • Anemia, Iron-Deficiency (complications, epidemiology)
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors
  • Heart Failure (epidemiology)
  • Humans
  • Iron
  • Middle Aged
  • Stroke Volume
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: